Literature DB >> 19494492

Plasma ghrelin levels and their relationship with gastric emptying in patients with dysmotility-like functional dyspepsia.

K J Lee1, D Y Cha, S J Cheon, M Yeo, S W Cho.   

Abstract

BACKGROUND/AIMS: Ghrelin affects gastric motility. However, little is known about the role of ghrelin in the pathophysiology of functional dyspepsia (FD). We investigated plasma ghrelin levels and their relationship with gastric emptying time in dysmotility-like FD patients.
METHODS: 42 patients with dysmotility-like FD and 14 healthy volunteers were enrolled in the study. Gastric half-emptying time was measured using a radiolabeled meal. Plasma total ghrelin levels before and after the meal were determined using a radioimmunoassay kit.
RESULTS: Preprandial ghrelin levels were significantly lower in FD patients than in controls. Postprandial ghrelin levels were similar between the two groups. Abnormally low preprandial ghrelin levels were observed in 7 out of 42 patients, in whom significant postprandial decrease of ghrelin levels was absent. Delayed gastric emptying was observed in 5 out of 7 patients with abnormally low ghrelin levels. Pre- or postprandial ghrelin levels were not significantly correlated with gastric half-emptying time, both in the patient group and in the control group.
CONCLUSIONS: Abnormally low preprandial ghrelin levels and absence of significant postprandial decrease of ghrelin levels are present in a subset of dysmotility-like FD patients. Further investigation on the pathogenetic implication of these alterations in FD is required. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494492     DOI: 10.1159/000215389

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  17 in total

1.  Functional dyspepsia.

Authors:  Rita Brun; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2010-05       Impact factor: 4.409

2.  Current and emerging therapies for the management of functional gastrointestinal disorders.

Authors:  Orla F Craig; Eamonn M M Quigley
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

Review 3.  Cyclic vomiting syndrome: treatment options.

Authors:  Reza A Hejazi; Richard W McCallum
Journal:  Exp Brain Res       Date:  2014-05-28       Impact factor: 1.972

4.  Changes in serum ghrelin level in relation to meal-time in patients with functional dyspepsia.

Authors:  Mh Kazemi; A Eshraghian; L Hamidpour; Sa Taghavi
Journal:  United European Gastroenterol J       Date:  2015-02       Impact factor: 4.623

5.  Duodenal implications in the pathophysiology of functional dyspepsia.

Authors:  Kwang Jae Lee; Jan Tack
Journal:  J Neurogastroenterol Motil       Date:  2010-07-26       Impact factor: 4.924

6.  Ghrelin and functional dyspepsia.

Authors:  Takashi Akamizu; Hiroshi Iwakura; Hiroyuki Ariyasu; Kenji Kangawa
Journal:  Int J Pept       Date:  2010-01-12

7.  Effect of amitriptyline on gastrointestinal function and brain-gut peptides: a double-blind trial.

Authors:  Wei Huang; Shu-Man Jiang; Lin Jia; Le-Qing You; Yao-Xing Huang; Yan-Mei Gong; Gui-Qin Wang
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

8.  Plasma dosage of ghrelin, IGF-1, GLP- 1 and leptin related to gastric emptying and esophageal pH-impedance in children with obesity.

Authors:  P Quitadamo; L Zenzeri; E Mozzillo; V Giorgio; A Rocco; A Franzese; G Nardone; A Staiano
Journal:  J Endocrinol Invest       Date:  2020-09-22       Impact factor: 4.256

9.  What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia?

Authors:  Hidekazu Suzuki; Juntaro Matsuzaki; Toshifumi Hibi
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

10.  Functional Dyspepsia in Review: Pathophysiology and Challenges in the Diagnosis and Management due to Coexisting Gastroesophageal Reflux Disease and Irritable Bowel Syndrome.

Authors:  Shadi S Yarandi; Jennifer Christie
Journal:  Gastroenterol Res Pract       Date:  2013-05-16       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.